ARCHIVES

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

This article is from The Cancer Letter archive.

Vol. 24 No. 07 | February 20, 1998

Download PDF Visit The Full Archive

Related Articles

NIH Panel Outlines Strategies To Manage Adrenal Tumors.

February 22, 2002

Letter: Headline Criticized On Letter About Consortium

June 21, 1996

Researchers Find Genetic Alterations in Triple-Negative Cancers Following Treatment

January 25, 2013

In Brief: Bleyer To Chair Childrens Cancer Study Group; Fisher To Advise; Penn. Awards Herberman

May 3, 1991

NIH Expands Minority Biomedical Research Training

July 11, 1975

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

September 8, 1978